Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROPEGINTERFERON ALFA-2B-NJFT Cause Illness? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Illness have been filed in association with ROPEGINTERFERON ALFA-2B-NJFT. This represents 0.6% of all adverse event reports for ROPEGINTERFERON ALFA-2B-NJFT.

8
Reports of Illness with ROPEGINTERFERON ALFA-2B-NJFT
0.6%
of all ROPEGINTERFERON ALFA-2B-NJFT reports
0
Deaths
1
Hospitalizations

How Dangerous Is Illness From ROPEGINTERFERON ALFA-2B-NJFT?

Of the 8 reports, 1 (12.5%) required hospitalization.

Is Illness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROPEGINTERFERON ALFA-2B-NJFT. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does ROPEGINTERFERON ALFA-2B-NJFT Cause?

Fatigue (298) Off label use (210) Pruritus (152) Headache (135) Inappropriate schedule of product administration (103) Product dose omission issue (99) Influenza like illness (97) Nausea (91) Diarrhoea (89) Arthralgia (88)

What Other Drugs Cause Illness?

DUPILUMAB (4,253) ADALIMUMAB (4,246) TOFACITINIB (3,905) SECUKINUMAB (2,436) LENALIDOMIDE (1,740) ETANERCEPT (1,730) HUMAN IMMUNOGLOBULIN G (1,626) TIRZEPATIDE (1,608) OMALIZUMAB (1,595) SEMAGLUTIDE (1,448)

Which ROPEGINTERFERON ALFA-2B-NJFT Alternatives Have Lower Illness Risk?

ROPEGINTERFERON ALFA-2B-NJFT vs ROPINIROLE ROPEGINTERFERON ALFA-2B-NJFT vs ROPIVACAINE ROPEGINTERFERON ALFA-2B-NJFT vs ROSIGLITAZONE ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN\ROSUVASTATIN

Related Pages

ROPEGINTERFERON ALFA-2B-NJFT Full Profile All Illness Reports All Drugs Causing Illness ROPEGINTERFERON ALFA-2B-NJFT Demographics